GlassScriptPhysician profile
Mara Stolber Thur
NPI 1295769511
$1,064.81
in general payments reported to CMS, 2019-2025
20 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.41 · 2020: $16.73 · 2021: $13.52 · 2022: $336 · 2023: $338 · 2024: $163 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $217.08 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Coopersurgical, INC. | $191.46 | 2022-2023 | Mara Console |
| Shield Therapeutics INC | $89.91 | 2024 | |
| Myovant Sciences INC. | $65.17 | 2022 | |
| Medtronic, INC. | $64.35 | 2022-2023 | Truclear |
| Mayne Pharma Commercial LLC | $61.58 | 2023-2025 | |
| Exeltis, USA INC. | $48.23 | 2023-2024 | Slynd |
| Organon LLC | $47.36 | 2022-2024 | |
| Sage Therapeutics, LLC | $43.80 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $39.66 | 2022 | |
| Sumitomo Pharma America, INC. | $27.27 | 2023 | Myfembree |
| Supernus Pharmaceuticals, INC. | $24.21 | 2025 | Qelbree |
| Astellas Pharma US INC | $22.92 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $20.15 | 2023 | |
| Meditrina | $18.66 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $18.03 | 2022 | |
| Covidien LP | $16.73 | 2020 | |
| Hologic Sales and Service, LLC | $16.49 | 2024 | Aptima |
| Olympus America INC. | $16.03 | 2023 | Olympus |
| Arjo INC. | $15.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mara Thur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.